Pharma & Cosmetics Global Market 2019 Top Key Players – Johnson & Johnson,  Roche,  Novartis,  Pfizer,  Sanofi and Forecast to 2026

Global Pharma & Cosmetics Market

WiseGuyRerports.com Presents “Global Pharma & Cosmetics Market Insights, Forecast to 2025” New Document to its Studies Database. The Report Contain 122 Pages With Detailed Analysis.

Description

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases. 

Pharmaceutical (OTC) occupies an important share in the pharmaceutical industry. Pharmaceuticals (OTC) can be classified into ointments, creams, gels and others according to drug properties. 

Cosmetics can be classified into skincare, haircare, oral care and others according to application situations, of which skincare occupies the largest share. 

The world pharma & cosmetics consuming market will still has a certain amount of growth. The world pharma & cosmetics production will increase at a growth rate of about 2.38%. 
With the development of economy, the world pharma & cosmetics capacity will continue to expand in the future and the main consumption region will be in NA and EU. 

 

Get sample Report @ https://www.wiseguyreports.com/sample-request/3717607-global-pharma-cosmetics-market-insights-forecast-to-2025

 

The global Pharma & Cosmetics market is valued at 1509500 million US$ in 2018 and will reach 1952700 million US$ by the end of 2025, growing at a CAGR of 3.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pharma & Cosmetics market based on company, product type, end user and key regions.

This report studies the global market size of Pharma & Cosmetics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pharma & Cosmetics in these regions. 

This research report categorizes the global Pharma & Cosmetics market by top players/brands, region, type and end user. This report also studies the global Pharma & Cosmetics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company: 
Johnson & Johnson 
Roche 
Novartis 
Pfizer 
Sanofi 
Eli Lilly 
GSK 
Bayer 
Merck & Co 
L' OREAL 
Unilever 
Procter & Gamble 
Estee Lauder 
Kao 
Shiseido 
Beiersdorf 
Henkel 
Shanghai Jahwa

Market size by Product 
By Pharma 
Ointments 
Creams 
Gels 
Others 
By Cosmetics 
Skin Products 
Hair and Scalp Products 
Oral Hygiene Products 
Market size by End User 
Pharmaceuticals, OTC 
Cosmetics

Market size by Region 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 
South Korea 
Australia 
Indonesia 
Singapore 
Malaysia 
Philippines 
Thailand 
Vietnam 
Europe 
Germany 
France 
UK 
Italy 
Spain 
Russia 
Central & South America 
Brazil 
Rest of Central & South America 
Middle East & Africa 
GCC Countries 
Turkey 
Egypt 
South Africa

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3717607-global-pharma-cosmetics-market-insights-forecast-to-2025

 

Table of Contents -Major Key Points

1 Study Coverage 
1.1 Pharma & Cosmetics Product 
1.2 Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global Pharma & Cosmetics Market Size Growth Rate by Product 
1.4.2 Ointments 
1.4.3 Creams 
1.4.4 Gels 
1.4.5 Others 
1.5 Market by End User 
1.5.1 Global Pharma & Cosmetics Market Size Growth Rate by End User 
1.5.2 Pharmaceuticals, OTC 
1.5.3 Cosmetics 
1.6 Study Objectives 
1.7 Years Considered

…………

11 Company Profiles 
11.1 Johnson & Johnson 
11.1.1 Johnson & Johnson Company Details 
11.1.2 Company Business Overview 
11.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Revenue and Gross Margin (2014-2019) 
11.1.4 Johnson & Johnson Pharma & Cosmetics Products Offered 
11.1.5 Johnson & Johnson Recent Development 
11.2 Roche 
11.2.1 Roche Company Details 
11.2.2 Company Business Overview 
11.2.3 Roche Pharma & Cosmetics Sales, Revenue and Gross Margin (2014-2019) 
11.2.4 Roche Pharma & Cosmetics Products Offered 
11.2.5 Roche Recent Development 
11.3 Novartis 
11.3.1 Novartis Company Details 
11.3.2 Company Business Overview 
11.3.3 Novartis Pharma & Cosmetics Sales, Revenue and Gross Margin (2014-2019) 
11.3.4 Novartis Pharma & Cosmetics Products Offered 
11.3.5 Novartis Recent Development 
11.4 Pfizer 
11.4.1 Pfizer Company Details 
11.4.2 Company Business Overview 
11.4.3 Pfizer Pharma & Cosmetics Sales, Revenue and Gross Margin (2014-2019) 
11.4.4 Pfizer Pharma & Cosmetics Products Offered 
11.4.5 Pfizer Recent Development 
11.5 Sanofi 
11.5.1 Sanofi Company Details 
11.5.2 Company Business Overview 
11.5.3 Sanofi Pharma & Cosmetics Sales, Revenue and Gross Margin (2014-2019) 
11.5.4 Sanofi Pharma & Cosmetics Products Offered 
11.5.5 Sanofi Recent Development 
11.6 Eli Lilly 
11.6.1 Eli Lilly Company Details 
11.6.2 Company Business Overview 
11.6.3 Eli Lilly Pharma & Cosmetics Sales, Revenue and Gross Margin (2014-2019) 
11.6.4 Eli Lilly Pharma & Cosmetics Products Offered 
11.6.5 Eli Lilly Recent Development 

……..CONTINUED

 

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, Industry research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)             

This release was published on openPR.